Fundraising Fox
Sherpa Healthcare Partners
Private equityGrand Cayman · Seed–Late Stage · 3 people tracked
Also known as SHERPA HEALTHCARE PARTNERS CO., LTD.
Find your way into Sherpa Healthcare Partners
Sign up to see every warm intro you have to Sherpa Healthcare Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sherpa Healthcare Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Early- to growth-stage biotech and life sciences firm with a cross-border US–China–Germany–France focus, deep-science and platform specialization, experienced pre-assembled team, and go-to syndicate partner for complex Series A/B rounds.
Source: firm website, verified Sep 29, 2026.
Team · 3 people
from public directoriesWhat they invest in
from 9 of 9 portfolio companiesBiotech ×9Healthtech ×7Deep Tech ×5Medical Devices ×4Advanced Manufacturing ×1AI & Machine Learning ×1Digital Health ×1FoodTech ×1
HQs:China×5United States×2Germany×1
Investments · 9 tracked
founders shown can be your intro pathBy year:2022 · 32021 · 47 dated
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures Capital3H Health InvestmentYuanBio Venture Capital
Bota offers engineered protein solutions through strain optimization and screening, leveraging proprietary datasets to increase protein yield while reducing production costs for industrial biotech applications.
Advanced ManufacturingBiotechDeep TechFoodTechNew Materials
Dr. Cheryl Cui(CEO)
Co-investorsHongShan Capital GroupNSG VenturesSource Code CapitalMatrix Partners China
Cerberus Therapeutics is a biotechnology company developing therapeutics based on nanobody technology, a tolerance induction platform, and a KappaLink platform.
BiotechDeep TechHealthtechBoston, US
Novalia Pishesha(Founder)inHidde Ploegh(Founder)Novalia Pishesha, PhD(Co-founder, BoD, SAB)Hidde L. Ploegh, PhD(Co-Founder, SAB)Harvey F. Lodish, PhD(Co-Founder, BoD)Xiaohong Sang(Executive Officer)
Co-investorsBill & Melinda Gates Foundation
ClinChoice operates a network of investigator sites that participate in clinical studies to support drug and device development.
BiotechHealthtechMedical DevicesPhiladelphia, US
Dr. John Balian(CEO)
Co-investorsDFJ DragonFundDraper AssociatesDraper DragonApricot CapitalLegend CapitalLilly Asia Ventures
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.
BiotechDeep TechHealthtech
Co-investorsLAVLilly Asia VenturesWI Harper Group3H Health InvestmentAlwin CapitalBioTrack Capital+2 more
Epimab Biotherapeutics is a clinical-stage biopharmaceutical company specializing in the development of bispecific antibodies using proprietary technology platforms including FIT-Ig® and MAT-Fab.
BiotechHealthtechMedical DevicesShanghai, CN
Wu Chenbing(Founder/Expert)
Co-investorsDecheng CapitalShangBay Capital LLCTCG Labs3E Bioventures Capital
Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases.
BiotechDeep TechHealthtech
Liqun Wang(Founder)
Co-investorsPan-Lin CapitalAlwin CapitalIDG CapitalLilly Asia Ventures
Singleron Biotechnologies develops single-cell and single-nucleus sequencing kits and solutions for transcriptome analysis of biological samples.
BiotechMedical DevicesCologne, DE
Co-investorsARCH Venture PartnersLAVLilly Asia VenturesLake Bleu CapitalMSA CapitalSBCVC+1 more
Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs.
AI & Machine LearningBiotechDeep TechHealthtechBeijing, CN
Co-investorsCenova CapitalQuan Capital3H Health InvestmentMSA Capital
Fund performance · per public LP disclosures · 3
as of Sep 2025| Fund | Vintage | Committed | Net IRR | TVPI | DPI |
|---|---|---|---|---|---|
| Sherpa Healthcare Fund IILPs: Oregon Public Employees Retirement System | 2021 | — | 2.5% | 1.08x | 0.10x |
| Sherpa Healthcare Co-Investment FundLPs: Oregon Public Employees Retirement System | 2020 | — | -1.6% | 0.94x | 0.00x |
| Sherpa Healthcare Fund ILPs: Oregon Public Employees Retirement System | 2019 | — | 6.7% | 1.33x | 0.15x |
Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).
Frequently asked questions
- How many investments has Sherpa Healthcare Partners made?
- Sherpa Healthcare Partners has 9 tracked investments.
- What stage does Sherpa Healthcare Partners invest at?
- Sherpa Healthcare Partners invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Sherpa Healthcare Partners focus on?
- Sherpa Healthcare Partners focuses on Biotech, Healthtech, Medical Devices.
- Where is Sherpa Healthcare Partners located?
- Sherpa Healthcare Partners is headquartered in Grand Cayman, CN.
- Does Sherpa Healthcare Partners lead rounds?
- Sherpa Healthcare Partners typically participates in rounds rather than leading them.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.